Approvals/TGA/ARIPENA aripiprazole 400 mg powder and diluent for prolonged release suspension for injection vial kit

Approved

STANDARD

ARIPENA aripiprazole 400 mg powder and diluent for prolonged release suspension for injection vial kit

Sun Pharma ANZ Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d199560f96d9e9af
Product Name: ARIPENA aripiprazole 400 mg powder and diluent for prolonged release suspension for injection vial kit
Artg Id: 444951
Artg Name: ARIPENA aripiprazole 400 mg powder and diluent for prolonged release suspension for injection vial kit
Sponsor: Sun Pharma ANZ Pty Ltd
Company Detail Path: /organization/sun-pharma-anz-pty-ltd
Artg Date: 2025-02-12
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/e0b9362241eac4f0c97be37e5c289791.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/6ffe2df4c8c13d244d6c958b29544b76.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

d199560f96d9e9af

Type

Standard